Myth: Cancer Treatment — Is Worse Than the Disease

Side effects vary enormously depending on which treatment you have, at what dose, and how your body responds. Some people work through chemotherapy with manageable fatigue. Others have a more difficult time. What has changed dramatically is how much can now be done to prevent and treat side effects — anti-nausea drugs, growth factors, targeted supportive medicines. Ask your oncologist specifically which side effects are likely for your regimen, because the general picture is less useful to you than what your specific treatment typically causes.

For the vast majority of cancers, leaving them untreated means allowing them to grow, invade nearby structures, and spread to distant sites. As that happens, the cancer itself causes increasing pain, fatigue, breathlessness, difficulty eating, and organ failure. A very small number of very slow-growing, low-risk tumours are genuinely managed with active surveillance rather than treatment — and if yours is one of them, your oncologist will say so clearly. That is not the general case.

Possibly, and it is always worth telling your oncologist how you are feeling rather than stopping without discussion. Many regimens can be adjusted — dose reduced, schedule changed, a short pause taken — in response to side effects. Those adjustments are part of managing treatment, not a sign of failure. Stopping without telling your team risks both the cancer and your ability to restart on a schedule that works. The conversation is always worth having.

Tell your oncologist. They have almost certainly had this conversation before, and many centres can arrange for a family member to join an appointment so your doctor can address the concern directly. Fear of treatment is usually based on something real — a story, a memory, a worry — and it is worth understanding where it comes from. You are entitled to make your own decision. You are also entitled to have accurate information before you make it.

For a small number of specific, very slow-growing cancers — certain low-risk prostate cancers, some early thyroid cancers — active surveillance rather than immediate treatment is a recognised clinical choice endorsed by NCCN and other bodies. That is a specific recommendation based on specific evidence, not a general principle. For the majority of cancers, treatment consistently improves both survival and quality of life compared with leaving the cancer alone. Ask your oncologist to explain the evidence for your specific case.